PPARG and neuroblastoma: Recent studies show that this hexapeptide is able to affect the peroxisome proliferator-activated receptor gamma (Pparγ) in mouse astrocytes and undifferentiated neuroblastoma cells (SH-SY5Y) in vitro [9, 10].